Alnylam

Amvuttra
Marketing

Alnylam rebuked by FDA over efficacy claims on Amvuttra website

The FDA hit Alnylam with an untitled letter over a website, accusing the biotech of presenting open-label data that create a misleading impression.
Nick Paul Taylor May 7, 2026 5:18am
Space shuttle takes off on background of blue sky

As questions swirl, Alnylam eyes ATTR market leadership by 2030

Mar 26, 2026 2:08pm
Collage poster study of businessmen picture chart arrow goes up

Orphan drug sales to surge past $400B in 2032: report

Mar 12, 2026 8:20am
Lifeline
Favicon Fierce Biotech

Midsize biotechs form coalition to fight against MFN policy

Feb 25, 2026 1:05pm
red tape delay stop error tie down stall

Alnylam hits profitability in Q4 despite Amvuttra revenue miss

Feb 12, 2026 11:05am
Cable car on San Francisco street

JPM26, Day 1: BMS CEO touts portfolio of blockbuster hopefuls

Jan 12, 2026 11:25pm